MOA Life Plus Co. Ltd. (KOSDAQ:142760)
South Korea · Delayed Price · Currency is KRW 845.00
0.00 (0.00%)
At close: Feb 19, 2026
MOA Life Plus Market Cap
MOA Life Plus has a market cap or net worth of 32.89 billion as of February 20, 2026. Its market cap has decreased by -22.17% in one year.
Market Cap
32.89B
Enterprise Value
32.43B
Revenue
9.80B
Ranking
n/a
PE Ratio
n/a
Stock Price
845.00
Market Cap Chart
Since July 7, 2016, MOA Life Plus's market cap has decreased from 97.39B to 32.89B, a decrease of -66.23%. That is a compound annual growth rate of -10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 32.89B | -52.55% |
| Dec 30, 2025 | 69.32B | 51.95% |
| Dec 30, 2024 | 45.62B | -33.64% |
| Dec 28, 2023 | 68.75B | -38.77% |
| Dec 29, 2022 | 112.27B | -53.08% |
| Dec 30, 2021 | 239.30B | 38.34% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.31B |
| EyeGene | 62.12B |
| NGeneBio | 57.46B |
| J2KBIO | 49.53B |
| Aptamer Sciences | 44.28B |
| SCM Lifescience | 37.31B |
| Kainos Medicine | 35.56B |